Krummen previously served as president and chief operating officer of the San Diego-based company. He was responsible for the clinical, regulatory, engineering and operations and will continue to oversee the efforts while growing the company’s commercial and sales teams as CEO.
The company is developing vMap, a non-invasive cardiac arrhythmia mapping platform that takes less than three minutes to allow clinicians to input case information, upload and markup an ECG and receive a 3D interactive arrhythmia source location map to visualize the heart. Krummen’s appointment comes as the company transitions to a commercial company and focuses on the pilot roll-out of vMap.
“Vektor Medical has a unique opportunity to revolutionize the standard of care for arrhythmias, and I look forward to working hard alongside our brilliant team to bring this technology to many more people suffering from serious heart rhythm disorders,” Krummen said in a news release.
Prior to joining the company, Krummen was a partner at Vorys, Sater, Seymour and Pease and was the deputy solicitor general for the state of Ohio.
“It’s been an honor to lead Vektor through the development and launch of our first product. I’ve worked side by side with Rob these last four years and I am confident in his leadership as he takes Vektor into this next phase of growth,” Mike Monko, Vektor Medical executive chairperson, said. “I remain committed to partnering with the team to improve outcomes in cardiac patient care.”
